Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma by Julia Wendler, Richard I. Lewis, Alexandra Kutilina, Markus Knott, Lisa Kristina Isbell, Elke Valk, Peter Borchmann, Jan-Michel Heger, Gerald Illerhaus, Elisabeth Schorb

Get full text

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients by Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Susanne Jung, Susanne Jung, Susanne Jung, Marcel Wacker, Marcel Wacker, Yacine Maringer, Yacine Maringer, Annika Nelde, Annika Nelde, Jens Bauer, Jens Bauer, Jens Bauer, Monika Denk, Monika Denk, Monika Denk, Naomi Hoenisch-Gravel, Naomi Hoenisch-Gravel, Marion Richter, Marion Richter, Marion Richter, Melek T. Oezbek, Melek T. Oezbek, Marissa L. Dubbelaar, Marissa L. Dubbelaar, Marissa L. Dubbelaar, Marissa L. Dubbelaar, Tatjana Bilich, Tatjana Bilich, Tatjana Bilich, Marina Pumptow, Peter Martus, Gerald Illerhaus, Claudio Denzlinger, Francesca Steinbach, Walter-Erich Aulitzky, Martin R. Müller, Daniela Dörfel, Hans–Georg Rammensee, Hans–Georg Rammensee, Hans–Georg Rammensee, Helmut R. Salih, Helmut R. Salih, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz

Get full text